Breaking Down ASH 2024: Key Myelofibrosis Research Findings

By Prithviraj Bose, MD, Francesca Palandri, MD, PhD, Andrew Kuykendall, MD, Lucia Masarova, MD - Last Updated: January 14, 2025

In this engaging video, Prithviraj Bose, MD, of MD Anderson Cancer Center, Francesca Palandri, MD, PhD, of Università di Bologna, Andrew Kuykendall, MD, of Moffitt Cancer Center, and Lucia Masarova, MD, of the MD Anderson Cancer Center, discuss the most exciting myelofibrosis abstracts presented at the 66th American Society of Hematology Annual Meeting & Exposition. These esteemed experts share their analysis of groundbreaking data, key takeaways for clinical practice, and the potential impact on the future of myelofibrosis treatment.

Advertisement

Post Tags:ASH 2024: MF
Advertisement
Advertisement
Advertisement